IGF::OT::IGF NEUROPSYCHOLOGICAL ASSESSMENT SYSTEM FOR CANCER PATIENTS
IGF::OT::IGF NEUROPSYCHOLOGICAL ASSESSMENT SYSTEM FOR CANCER PATIENTS
批准号:
9361727
负责人:
LINDSAY ALLEN
金额:
$22.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-19 至 2017-06-18
关键词:
AdministratorAdverse effectsAffectCancer PatientCancer SurvivorCognitiveComputer softwareDataFlowchartsGoalsHearingIndividualInstitutional Review BoardsInstructionIntellectual PropertyLearningLifeNeurocognitiveOutputPatient Self-ReportPatientsPhaseProtocols documentationQualifyingQuality of lifeReaction TimeResearchResearch PersonnelResolutionScheduleSecureSelf AdministrationSelf-AdministeredSystemTeleconferencesTestingTimeTrainingbasecancer therapycognitive abilitycommercializationdesigngraphical user interfacehuman studymedication compliancemeetingsmobile applicationneuropsychologicalprototyperelational databasespeech recognitionusabilityweb portal
中文摘要
认知能力下降是许多癌症幸存者的主要生活质量问题。这个问题是受
英文摘要
Decline in cognitive ability is a major quality-of-life problem for many cancer survivors. This problem is affected by
which treatments a particular individual receives. Unfortunately, research has provided little guidance on which
treatment may be best for an individual based on unfavorable cognitive side effects. To help researchers fill this
information gap, and provide doctors and patients with the guidance they need, we propose to develop a
neuropsychological assessment system that is designed specifically for cancer patients and survivors. This system is
mobile, self-administered, and has minimal practice effects. The neurocognitive content has been proven sensitive to
the subtle cognitive effects of cancer treatment and is appropriate for repeated administration. The mobile battery is
cross-platform and uses instruction videos and speech recognition for self-administration and automated scoring. The
data from the battery is automatically uploaded to a secure server for scoring. Two web portals (one for clinicians, the
other for researchers) offer online ordering of tests, review of results, and even protocol customization. The Creare
team is very well qualified to develop and commercialize this system by leveraging software that Creare and its
collaborators have previously developed and validated for mobile neurocognitive assessment, mobile hearing
assessment, and medication adherence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOPIC 343: NEUROPSYCHOLOGICAL ASSESSMENT SYSTEM FOR CANCER PATIENTS
-
批准号:10033013
-
项目类别:
-
资助金额:$149.96万
-
财政年份:2019
-
负责人:LINDSAY ALLEN
-
依托单位:
海外基金